Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Phase EARLY_PHASE1 × NETWORK × Doxorubicin × Clear all

Phase

Phase 3 86 Phase 2 44 Phase 1 10 Phase 2/3 2 Phase NA 1 Phase EARLY_PHASE1 1 Phase 1/2 1

Status

Sponsor Class

OTHER 8 NETWORK 1

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Plasmablastic Lymphoma 1

Interventions

venetoclax 1 tafasitamab 1 prednylidene 1 glofitamab 1 deltacortene 1 daratumumab 1 Vincristine 1 Rituximab 1 Prednisone 1 Gemcitabine 1 Etoposide 1 Doxorubicin 1 Dexamethasone 1 Cyclophosphamide 1 Cisplatin 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT04139304 2025-06-29

A Study of Daratumumab and Dose-Adjusted EPOCH in Plasmablastic Lymphoma

AIDS Malignancy Consortium

Phase EARLY_PHASE1 Recruiting

Plasmablastic Lymphoma

Data powered by HemOnc (CC BY 4.0) Colophon ⚡